39 research outputs found
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer
Colorectal cancer remains a leading source of cancer mortality worldwide. Initial response is often followed by emergent resistance that is poorly responsive to targeted therapies, reflecting currently undruggable cancer drivers such as KRAS and overall genomic complexity. Here, we report a novel approach to developing a personalized therapy for a patient with treatment-resistant metastatic KRAS-mutant colorectal cancer. An extensive genomic analysis of the tumor's genomic landscape identified nine key drivers. A transgenic model that altered orthologs of these nine genes in the Drosophila hindgut was developed; a robotics-based screen using this platform identified trametinib plus zoledronate as a candidate treatment combination. Treating the patient led to a significant response: Target and nontarget lesions displayed a strong partial response and remained stable for 11 months. By addressing a disease's genomic complexity, this personalized approach may provide an alternative treatment option for recalcitrant disease such as KRAS-mutant colorectal cancer
Drosophila TIEG Is a Modulator of Different Signalling Pathways Involved in Wing Patterning and Cell Proliferation
Acquisition of a final shape and size during organ development requires a
regulated program of growth and patterning controlled by a complex genetic
network of signalling molecules that must be coordinated to provide positional
information to each cell within the corresponding organ or tissue. The mechanism
by which all these signals are coordinated to yield a final response is not well
understood. Here, I have characterized the Drosophila ortholog
of the human TGF-β Inducible Early Gene 1 (dTIEG). TIEG are zinc-finger
proteins that belong to the KrĂĽppel-like factor (KLF) family and were
initially identified in human osteoblasts and pancreatic tumor cells for the
ability to enhance TGF-β response. Using the developing wing of
Drosophila as “in vivo” model, the dTIEG
function has been studied in the control of cell proliferation and patterning.
These results show that dTIEG can modulate Dpp signalling. Furthermore, dTIEG
also regulates the activity of JAK/STAT pathway suggesting a conserved role of
TIEG proteins as positive regulators of TGF-β signalling and as mediators of
the crosstalk between signalling pathways acting in a same cellular context
Collective cell migration and metastases induced by an epithelial-to-mesenchymal transition in Drosophila intestinal tumors.
Metastasis underlies the majority of cancer-related deaths yet remains poorly understood due, in part, to the lack of models in vivo. Here we show that expression of the EMT master inducer Snail in primary adult Drosophila intestinal tumors leads to the dissemination of tumor cells and formation of macrometastases. Snail drives an EMT in tumor cells, which, although retaining some epithelial markers, subsequently break through the basal lamina of the midgut, undergo a collective migration and seed polyclonal metastases. While metastases re-epithelialize over time, we found that early metastases are remarkably mesenchymal, discarding the requirement for a mesenchymal-to-epithelial transition for early stages of metastatic growth. Our results demonstrate the formation of metastases in adult flies, and identify a key role for partial-EMTs in driving it. This model opens the door to investigate the basic mechanisms underlying metastasis, in a powerful in vivo system suited for rapid genetic and drug screens
A Jnk–Rho–Actin remodeling positive feedback network directs Src-driven invasion
Current models of tumor cell invasion propose that oncogenic signaling converges upon key orchestrators of cytoskeletal dynamics, including c-Jun N-terminal kinase (Jnk) and RhoGTPase family members; these signals dynamically direct Actin remodeling proteins (ARPs) to catalyze the cytoskeletal changes required for migration. Src is a key driver of tumor aggression, metastasis and patient mortality. To clarify how Src regulates Actin dynamics to promote invasive migration, we performed a genetic modifier screen in a Drosophila model of invasion. Nine genes linked to Actin dynamics were identified that mediate invasion in situ. We found that ARPs were required for many oncogenic effects of Src including Mmp1 expression and initiation of apoptosis. Surprisingly, they were also regulators of Jnk pathway activity: both Src and the small GTPase Rho1 activated Jnk in a manner dependent on ARPs during invasion. Our results suggest that ARPs are not simply downstream executors of signal transduction pathways. Rather, they participate in a positive feedback network involving canonical oncogenic signaling pathways that promote tumor invasion
A New Directed Signature Scheme With Hybrid Problems
Abstract In this paper, we proposed a new directed signature scheme based on hybrid problems; factoring and discrete logarithm. This scheme authorizes only an intended verifier to verify a resulting signature. In fact, both signer and verifier also should be able to prove the resulted signature to any third party whenever necessary. Until today, the security of many existing directed signatures is only based on a single hard problem like factoring, discrete logarithm or elliptic curve discrete logarithm. Although these schemes seem secure nowadays but in a near future, if an adversary finds a solution of these hard problems then the schemes will no longer be secured. Thus, we develop a newly designed scheme which provides greater security level than single hard problem-based scheme since it is impossible for the adversary to solve the two hard problems simultaneously